170
Views
11
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Efficacy and Safety of Budesonide Inhalation Powder (Pulmicort Turbuhaler®) During 52 Weeks of Treatment in Adults and Children with Persistent Asthma

, M.D., , M.D., , M.D., , M.D. & , M.D.
Pages 225-236 | Published online: 28 Apr 2003

References

  • Djukanovic R, Roche WR, Wilson JW, Beasley CR, Twentyman OP, Howarth RH, Holgate ST. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142(2)434–457
  • Lemanske RF, Jr, Busse WW. Asthma. JAMA 1997; 278(22)1855–1873
  • National Asthma Education and Prevention Program. Expert Panel Report II. Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051. National Heart, Lung, and Blood Institute; National Institutes of Health: Bethesda, MD, 1997
  • Spector SL, Nicklas RA. Practice parameters for the diagnosis and treatment of asthma. J Allergy Clin Immunol 1995; 96(2)707–870
  • Kamada AK, Szefler SJ. Glucocorticoids and growth in asthmatic children. Pediatr Allergy Immunol 1995; 6(3)145–154
  • Pedersen S, O'Byrne P. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997; 52(39 suppl)1–34
  • Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332(13)868–875
  • Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. Drugs 1992; 44(3)375–407
  • Johansson S-Å, Andersson K-E, Brattsand R, Gruvstad E, Hedner P. Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man. Eur J Respir Dis Suppl 1982; 122: 74–82
  • Thorsson L, Edsbäcker S, Conradson T-B. Lung deposition of budesonide from Turbuhaler® is twice that from a pressurized metered-dose inhaler P-MDI. Eur Respir J 1994; 7(10)1839–1844
  • Wetterlin K. Turbuhaler: a new powder inhaler for administration of drugs to the airways. Pharm Res 1988; 5(8)506–508
  • Kemp J, Wanderer AA, Ramsdell J, Southern DL, Weiss S, Aaronson D, Grossman J. Rapid onset of control with budesonide turbuhaler in patients with mild-to-moderate asthma. Ann Allergy Asthma Immunol 1999; 82(5)463–471
  • Busse WW, Chervinsky P, Condemi J, Lumry WR, Petty TL, Rennard S, Townley RG. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998; 101(4 Pt 1)457–463
  • Shapiro G, Bronsky EA, LaForce CF, Mendelson L, Pearlman D, Schwartz RH, Szefler SJ. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. J Pediatr 1998; 132(6)976–982
  • Pedersen S, Hanson OR, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 1990; 65: 308–310
  • Persson G, Olsson B, Soliman S. The impact of inspiratory effect on inspiratory flow through Turbuhaler® in asthmatic patients. Eur Respir J 1997; 10: 681–684
  • Nelson HS, Bernstein IL, Fink J, Edwards TB, Spector SL, Storms WW, Tashkin DP. For the pulmicort Turbuhaler study group. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Chest 1998; 113(5)1264–1271
  • Osterman K, Carlholm M, Ekelund J, Kiviloog J, Nikander K, Nilholm L, Salomonsson P, Strand V, Venge P, Zetterström O. Effect of 1 year daily treatment with 400 µg budesonide (Pulmicort® Turbuhaler®) in newly diagnosed asthmatics. Eur Respir J 1997; 10(10)2210–2215
  • Miyamoto T, Takahashi T, Nakajima S, Makino S, Yamakido M, Mano K, Nakashima M, Tollemar U, Selroos O. A double-blind, placebo-controlled steroid-sparing study with budesonide Turbuhaler in Japanese oral steroid-dependent asthma patients. Respirology 2000; 5(3)231–240
  • Aaronson D, Kaiser H, Dockhorn R, Findlay S, Korenblat P, Thorsson L, Kallen A. Effects of budesonide by means of the Turbuhaler on the hypothalamic-pituitary-adrenal axis in asthmatic subjects: a dose-response study. J Allergy Clin Immunol 1998; 101(3)312–319
  • Pauwels RA, Löfdahl C-G, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. For the formoterol and corticosteroids establishing therapy (FACET) international study group. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337(20)1405–1411
  • National Asthma Education and Prevention Program. Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma—Update on Selected Topics 2002. NIH Publica-tion No. 02-5075. National Heart, Lung, and Blood Institute; National Institutes of Health: Bethesda, MD, 2002
  • The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 2000; 343(15)1054–1063
  • Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343(15)1064–1069
  • Källén B, Rydhstroem H, Åberg A. Congenital malformations after the use of inhaled budesonide in early pregnancy. Obstet Gynecol 1999; 93(3)392–395
  • Ericson A, Källén B. Use of drugs during pregnancy—unique Swedish registration method that can be improved. Information from the Swedish Medical Products Agency 1999; 1: 8–11
  • Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids. Lessons for the new millennium. Drug Safety 2000; 23(1)11–33

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.